Arthritis, Rheumatoid: all 2,962 studies

Page 5 of 30. Open to participants first (396), then studies with results posted, then the rest; newest registration first within each.

• App-based Education and GOal-setting in Rheumatoid ArthritisCompletedNCT05888181Not applicableResults posted
• A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or PsoriasisCompletedNCT05796245Results posted
• Effects of Administration of SCFA in Rheumatoid Arthritis Inadequate RespondersCompletedNCT05718583Not applicableResults posted
• To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting.CompletedNCT05576051Results posted
• First in Human Study of a Monoclonal Antibody (SOL-116) Targeting BSSL (Bile Salt-Stimulated Lipase), Single and Multiple Dose PartsCompletedNCT05576012Phase 1Results posted
• Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid ArthritisCompletedNCT05572567Results posted
• Effects of a Mobile Application RA Joint Protection and Activity Self-management ProgramCompletedNCT05570175Not applicableResults posted
• A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid ArthritisTerminatedNCT05516758Phase 2Results posted
• A Study to Compare Efficacy and Safety of CT-P47 and RoActemra in Patients With Rheumatoid ArthritisCompletedNCT05489224Phase 3Results posted
• A Study To Describe The Use Of Tofacitinib After Use Of Rituximab In Patients With Rheumatoid Arthritis In A Real-World SettingCompletedNCT05487703Results posted
• Phase 2b Study of MBS2320 in Participants With Methotrexate-Refractory RACompletedNCT05460832Phase 2Results posted
• A Study to Investigate Safety, Tolerability, and PK of Oral Doses of TCK-276 in Patients With Rheumatoid ArthritisCompletedNCT05437419Phase 1Results posted
• Acupressure in Rheumatoid ArthritisCompletedNCT05412121Not applicableResults posted
• This is a Retrospective Observational Study Looking at the Characteristics and Outcomes of Participants Taking Inflectra Using the CorEvitas Rheumatoid Arthritis RegistryCompletedNCT05375942Results posted
• CD40L Antagonism in Rheumatoid Arthritis (RA)TerminatedNCT05306353Phase 2Results posted
• Phone-Based Based Walk With Ease Program for Adults With ArthritisCompletedNCT05289544Not applicableResults posted
• ATI-450 Plus Methotrexate (MTX) Versus Placebo Plus MTX in Participants With Moderate to Severe Active Rheumatoid Arthritis (RA)CompletedNCT05279417Phase 2Results posted
• 2-HOBA Phase 2 Clinical Trial in Rheumatoid ArthritisCompletedNCT05274243Phase 2Results posted
• Tc 99m Tilmanocept Imaging for Early Prediction of Anti-TNFα Therapy Response in Moderate to Severe Active RATerminatedNCT05246280Phase 3Results posted
• Study to Assess the Safety, Pharmacokinetics, and Efficacy of KPL-404 in Participants With Rheumatoid Arthritis With Inadequate Response or Intolerance to at Least One Biologic Disease-modifying Anti-rheumatic Drug or a Janus Kinase InhibitorCompletedNCT05198310Phase 2Results posted
• Breaking Implicit Bias Habits: An Individuation Pilot Study In RheumatologyCompletedNCT05116163Not applicableResults posted
• COVID-19 Booster Vaccine in Autoimmune Disease Non-RespondersTerminatedNCT05000216Phase 2Results posted
• A Proof-of-concept Study of the Efficacy and Safety of Nipocalimab in Participants With Active Rheumatoid ArthritisCompletedNCT04991753Phase 2Results posted
• Development of a Normative Database for Rheumatoid Arthritis (RA) Imaging With Tc99m TilmanoceptCompletedNCT04947137Phase 2Results posted
• A Study to Compare the Response to Treatment With Abatacept vs Adalimumab, on Background Methotrexate, in Adults With Early, Seropositive, and Shared Epitope-positive Rheumatoid Arthritis and an Inadequate Response to MethotrexateActive, not recruitingNCT04909801Phase 3Results posted
• Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 18 to 75 Years of Age Treated With Subcutaneous (SC) Injections of ABBV-154 for Moderately to Severely Active Rheumatoid Arthritis (RA)TerminatedNCT04888585Phase 2Results posted
• A Study to Assess the Pharmacokinetics of Certolizumab Pegol in Adults With Active Rheumatoid ArthritisCompletedNCT04740814Phase 1Results posted
• Comparative Effectiveness Of Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier Lines Of Therapy And Use As Monotherapy.CompletedNCT04721821Results posted
• A Study To Investigate And Describe The Treatment Patterns And Effect Of Tofacitinib Indicators For Patients With Rheumatoid ArthritisCompletedNCT04721808Results posted
• Ultrasound Efficacy in Moderate Rheumatoid ArthritisCompletedNCT04662359Not applicableResults posted
• A Study of LY3462817 in Participants With Rheumatoid ArthritisCompletedNCT04634253Phase 2Results posted
• Study to Evaluate Organic Anion Transporting Polypeptide (OATP) Transporter-Mediated Drug-Drug Interactions Between Filgotinib and Statins as Probe Drugs in Healthy ParticipantsCompletedNCT04608344Phase 1Results posted
• A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Moderately to Severely Active Rheumatoid Arthritis and an Inadequate Response to MethotrexateCompletedNCT04577781Phase 2Results posted
• Vagus Nerve Stimulation for Moderate to Severe Rheumatoid ArthritisActive, not recruitingNCT04539964Phase 3Results posted
• MSB11456 in Participants With Moderately to Severely Active Rheumatoid ArthritisCompletedNCT04512001Phase 3Results posted
• Regulation of Mucosal Healing in Inflammatory Bowel DiseaseCompletedNCT04504136Not applicableResults posted
• Cardiovascular Risk Assessment for Patients With Rheumatoid Arthritis Arthritis:CompletedNCT04488497Not applicableResults posted
• Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) PatientsCompletedNCT04428424Results posted
• TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833, PF-06651600, AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATECompletedNCT04413617Phase 2Results posted
• Weight Loss and Exercise To Improve Rheumatoid Arthritis Cardiovascular RiskCompletedNCT04356183Not applicableResults posted
• ROSA Total Knee Post Market Study EMEACompletedNCT04338893Not applicableResults posted
• Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA)TerminatedNCT04333147Phase 3Results posted
• A Phase III Transition Study of DRL Rituximab to Reference Medicinal ProductsCompletedNCT04268771Phase 3Results posted
• This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheumatoid Arthritis Patients.CompletedNCT04267614Results posted
• A Study To Compare The Effectiveness Of Tofacitinib 11 Mg Once A Day To Tofacitinib 5 Mg Twice A DayCompletedNCT04267380Results posted
• Study of ATI-450 Plus Methotrexate (MTX) vs MTX Alone in Patients With Moderate to Severe RACompletedNCT04247815Phase 2Results posted
• Study in Subjects With Rheumatoid Arthritis to Evaluate the Effect of a Single Dose of Olokizumab on the Pharmacokinetics of Substrates for CYP1A2, CYP2C9, CYP2C19 and CYP3A4CompletedNCT04246762Phase 1Results posted
• A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid ArthritisCompletedNCT04230213Phase 3Results posted
• Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid ArthritisCompletedNCT04186871Phase 2Results posted
• A Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P17 in Patients With Active Rheumatoid ArthritisCompletedNCT04171414Phase 3Results posted
• A Study to Evaluate the Safety and Efficacy of VIB4920 in Participants With Rheumatoid ArthritisCompletedNCT04163991Phase 2Results posted
• A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)CompletedNCT04163016Phase 1Results posted
• Efficacy and Safety of GSK3196165 (Otilimab) Versus Placebo and Sarilumab in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological Disease-modifying Antirheumatic Drug (DMARDs) and/or Janus Kinase (JAK) InhibitorsCompletedNCT04134728Phase 3Results posted
• A Study of Baricitinib in Participants With Rheumatoid ArthritisCompletedNCT04086745Phase 4Results posted
• Predictors of Response to Tofacitinib Treatment in Rheumatoid Arthritis PatientsCompletedNCT04079920Results posted
• Comparison of Tc 99m Tilmanocept Imaging With IHC Analysis of CD206 Expression in Synovial Tissue of Subjects With RATerminatedNCT04078191Phase 2Results posted
• A Study to Evaluate the Effectiveness and Safety of SKI-O-703 in Patients Experiencing Active Rheumatoid Arthritis Despite Treatment With Conventional Therapies.CompletedNCT04057118Phase 2Results posted
• A Study to Evaluate Patient Characteristics and Treatment Patterns Among Rheumatoid Arthritis PatientsCompletedNCT04047121Results posted
• Comparative Analysis of Adherence and Effectiveness Outcomes Between Rheumatoid Arthritis (RA) Patients Treated With Tofacitinib Modified Release (MR)CompletedNCT04018001Results posted
• A Study of the Safety, Tolerability and Efficacy of Treatment With AP1189 in Early RA Patients With Active Joint DiseaseCompletedNCT04004429Phase 2Results posted
• Changes of Depression After First-year of Tofacitinib in RA PatientsCompletedNCT03992781Results posted
• IDentification of Factors Predictive of Tofacitinib's Survival in Patient With Rheumatoid ArthritisCompletedNCT03981900Results posted
• Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to MethotrexateCompletedNCT03980483Phase 3Results posted
• Comparative Analysis of Outcomes Among Patients Initiating Xeljanz in Combination With Oral MTX Who Withdraw MTX Versus Continue MTXCompletedNCT03975790Results posted
• Meditation Effects on Brain Function in Rheumatoid ArthritisCompletedNCT03975595Not applicableResults posted
• Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs)TerminatedNCT03970837Phase 3Results posted
• Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs BiologicsCompletedNCT03964649Results posted
• Evaluation of the Precision and Sensitivity of Tilmanocept Uptake Value (TUV) on Tc 99m Tilmanocept Planar ImagingCompletedNCT03938636Phase 2Results posted
• Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial SpondyloarthritisCompletedNCT03926195Phase 2Results posted
• A Study of Baricitinib (LY3009104) in Participants With Rheumatoid ArthritisCompletedNCT03915964Phase 4Results posted
• Novel PET Radioligand as an Inflammatory Biomarker in Musculoskeletal ConditionsTerminatedNCT03912428Phase 1Results posted
• Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Rheumatoid Arthritis)CompletedNCT03885037Results posted
• A Study to Evaluate Biomarkers to Predict Efficacy of Abatacept in Rheumatoid ArthritisCompletedNCT03882008Phase 4Results posted
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of ABBV-3373 in Participants With Moderate to Severe Rheumatoid Arthritis (RA)CompletedNCT03823391Phase 2Results posted
• A Study in Rheumatoid Arthritis Patients Who Have Completed a Preceding Study With ABBV-105 Given Alone or in Combination With UpadacitinibTerminatedNCT03823378Phase 2Results posted
• Study of Two Doses of ABX464 in Participants With Moderate to Severe Rheumatoid ArthritisCompletedNCT03813199Phase 2Results posted
• A Study to Compare Efficacy and Safety of CT-P17 With Humira in Patients With Active Rheumatoid ArthritisCompletedNCT03789292Phase 3Results posted
• Etanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid ArthritisTerminatedNCT03781375Phase 3Results posted
• Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)CompletedNCT03780959Phase 2/3Results posted
• A Study to Evaluate the Pharmacokinetics of Abatacept Converted From Drug Substance by Two Different ProcessesCompletedNCT03714022Phase 1Results posted
• Rheumatoid Arthritis Satisfaction Outcome ResearchCompletedNCT03703817Results posted
• NSAIDs vs. Coxibs in the Presence of AspirinTerminatedNCT03699293Phase 4Results posted
• Phase 1/2a Clinical Trial to Assess the Safety of HB-adMSCs for the Treatment of Rheumatoid ArthritisCompletedNCT03691909Phase 1/2Results posted
• A Study to Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 Combination) in Participants With Active Rheumatoid ArthritisCompletedNCT03682705Phase 2Results posted
• Comorbidities and Outcomes in Early Rheumatoid ArthritisCompletedNCT03675516Results posted
• Rheumatoid Arthritis Memory B Cells and AbataceptCompletedNCT03652961Phase 4Results posted
• Dietary Salt in Rheumatoid ArthritisCompletedNCT03649178Not applicableResults posted
• COBRA-Slim With or Without Fast Access to TNF Blockade for Remission Induction in Early RACompletedNCT03649061Phase 4Results posted
• Effects of Abatacept on Myocarditis in Rheumatoid ArthritisTerminatedNCT03619876Phase 4Results posted
• Clinical Efficacy and Safety of Leflunomide in Egyptian Patients With Active Rheumatoid ArthritisCompletedNCT03599986Results posted
• Evaluation of the Optimal MTX Dose as an Add-on Therapy to Adalimumab for RA Patients in Japan, South Korea and TaiwanCompletedNCT03505008Phase 4Results posted
• Effects of a Rheumatoid Arthritis Self-management ProgramCompletedNCT03470740Not applicableResults posted
• Effect of Sarilumab on Patient-reported Outcomes in Patients With Active Rheumatoid ArthritisCompletedNCT03449758Phase 4Results posted
• First-time-in-Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single (in Both Fed and Fasted States) or Repeat Doses of GSK3358699TerminatedNCT03426995Phase 1Results posted
• Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic FunctionCompletedNCT03417778Phase 1Results posted
• Safety and Efficacy of Efavaleukin Alfa in Subjects With Active Rheumatoid ArthritisTerminatedNCT03410056Phase 1/2Results posted
• an On-demand Program to EmpoweR Active Self-management (OPERAS)CompletedNCT03404245Not applicableResults posted
• Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid ArthritisCompletedNCT03387423Results posted
• Early Phase Study to Assess Efficacy and Safety of AZD9567 Versus Prednisolone in Patients With Rheumatoid ArthritisCompletedNCT03368235Phase 2Results posted
• Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's DiseaseCompletedNCT03357471Phase 3Results posted

← Arthritis, Rheumatoid overview